Hospital Universitario De La Princesa
Hospital Universitario De La Princesa is recorded as a service provider in 9 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 9 of 9 trials · Latest update first
Randomised, bioequivalence clinical trial of ezetimibe/atorvastatin 10 mg/40 mg tablets versus ezetimibe/atorvastatin 10 mg/40 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions in crossover replicated design
Sponsor Laboratorios Normon S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomised, bioequivalence clinical trial of ezetimibe/atorvastatin 10 mg/80 mg tablets versus ezetimibe/atorvastatin 10 mg/80 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions in crossover replicated design.
Sponsor Laboratorios Normon S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomised bioequivalence clinical trial of sacubitril/valsartan 97 mg/103 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions in crossover replicated design.
Sponsor Laboratorios Normon S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomised bioequivalence clinical trial of sacubitril/valsartan 49 mg/51 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions in crossover replicated design.
Sponsor Laboratorios Normon S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomised, crossover bioequivalence clinical trial of hydrochlorothiazide 25 mg tablets, after a single oral dose administration to healthy volunteers under fasting conditions.
Sponsor Laboratorios Normon S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomised, crossover bioequivalence clinical trial of ezetimibe/atorvastatin 10 mg/80 mg tablets versus ezetimibe/atorvastatin 10 mg/80 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions
Sponsor Laboratorios Normon S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomised, crossover bioequivalence clinical trial of apixabán 5 mg film coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.
Sponsor Laboratorios Normon S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomised, crossover bioequivalence clinical trial of rosuvastatin/ezetimibe 20 mg/ 10 mg film-coated tablets versus rosuvastatin/ezetimibe 20 mg/ 10 mg hard capsules, after a single oral dose administration to healthy volunteers under fasting conditions.
Sponsor Laboratorios Normon S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomised, crossover bioequivalence clinical trial of pregabalin 300 mg tablets versus pregabalin 300 mg hard capsules, after a single oral dose administration to healthy volunteers under fasting conditions.
Sponsor Laboratorios Normon S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Hospital Universitario De La Princesa?
The 2026-10-09 snapshot links Hospital Universitario De La Princesa to 9 distinct CTIS trials. Recorded services include Data management, Laboratory services, Medical writing, Statistical analysis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Hospital Universitario De La Princesa?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Hospital Universitario De La Princesa conducted?
The linked trials record locations in 1 country, including Spain. These are trial locations, not confirmed office locations or countries where Hospital Universitario De La Princesa delivered services.
What can this page tell me about Hospital Universitario De La Princesa's trial experience?
Browse 9 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Hospital Universitario De La Princesa. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Hospital Universitario De La Princesa